Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
 EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

Volume 12, Number 7, July 2006

European Bat Lyssavirus Type 2 RNA in Myotis daubentonii

Nicholas Johnson,* Philip R. Wakeley,* Sharon M. Brookes,* and Anthony R. Fooks*
*Veterinary Laboratories Agency, Addlestone, Surrey, United Kingdom

 
 
Figure.
  Back to article
 

Figure. Results of quantitative polymerase chain reaction (PCR) of viral genome copies within organ samples taken from 2 Daubenton's bats infected with European bat lyssavirus type 2 (EBLV-2). A) Standard curve of duplicate dilutions of known quantities of EBLV-2 amplicon. A 20% (vol/vol) sample (10-fold dilution series) separated by electrophoresis on a 1% agarose gel is shown in the inset. Ct, threshold value. B) Real-time PCR amplification of EBLV-2 genomic RNA from organ samples from a bat (696/04) in Lancashire, United Kingdom infected with EBLV-2. dR, fluorescence change generated by a baseline-corrected algorithm calculated from every amplification cycle. A 20% (vol/vol) sample of each amplification separated by electrophoresis on a 1% agarose gel is shown in the inset. Br, brain; To, tongue; Li, liver; Ki, kidney; In, intestine; St, stomach; -, negative sample (no template); +, positive sample from a previous human case (5).

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed June 15, 2006

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention